Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease.

Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease.

Protocatechuic aldehyde (PAL) has been reported to bind to DJ-1, a key protein involved in Parkinson's disease (PD), and exerts potential neuroprotective effects via DJ-1 in SH-SY5Y cells. In this study, we investigated the neuroprotective pharmacological effects of PAL against neurotoxin-induc...

Full description

Bibliographic Details
Main Authors:	Xin Zhao, Shenyu Zhai, Ming-Sheng An, Yue-Hua Wang, Ying-Fan Yang, Hui-Qi Ge, Jin-Hao Liu, Xiao-Ping Pu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3799719?pdf=render

Similar Items

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
by: Juan Segura-Aguilar
Published: (2017-01-01)

Antibiofilm effect and mechanism of protocatechuic aldehyde against Vibrio parahaemolyticus
by: Yawen Liu, et al.
Published: (2022-11-01)

Evaluation of the Therapeutic Effects of Protocatechuic Aldehyde in Diabetic Nephropathy
by: Yu-Teng Chang, et al.
Published: (2021-08-01)

β-Cyclodextrin Inclusion Complexes with Catechol-Containing Antioxidants Protocatechuic Aldehyde and Protocatechuic Acid—An Atomistic Perspective on Structural and Thermodynamic Stabilities
by: Thammarat Aree
Published: (2021-06-01)

DJ-1–Mediated Protective Effect of Protocatechuic Aldehyde Against Oxidative Stress in SH-SY5Y Cells
by: Jian-Wei Gao, et al.
Published: (2011-01-01)

Anti-EMT and anti-fibrosis effects of protocatechuic aldehyde in renal proximal tubular cells and the unilateral ureteral obstruction animal model
by: Yu-Teng Chang, et al.
Published: (2022-12-01)

Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease
by: E. Maruthi Prasad, et al.
Published: (2020-10-01)

Protocatechuic aldehyde increases pericyte coverage and mitigates pericyte damage to enhance the atherosclerotic plaque stability
by: Lei Zhang, et al.
Published: (2023-12-01)

G protein-coupled estrogen receptor-1 is involved in the protective effect of protocatechuic aldehyde against endothelial dysfunction.
by: Byung Soo Kong, et al.
Published: (2014-01-01)

Neuroprotective Effects of Aldehyde-Reducing Composition in an LPS-Induced Neuroinflammation Model of Parkinson’s Disease
by: Sora Kang, et al.
Published: (2023-12-01)

Protocatechuic aldehyde mitigates hydrogen peroxide-triggered PC12 cell damage by down-regulating MEG3
by: Zhiwei Zhong, et al.
Published: (2020-01-01)

Protocatechuic aldehyde from Salvia miltiorrhiza exhibits an anti-inflammatory effect through inhibiting MAPK signalling pathway
by: Shuang Wu, et al.
Published: (2020-11-01)

Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson’s Disease
by: Shankar J. Chinta, et al.
Published: (2018-01-01)

Synergistic Effects of Ginkgolide B and Protocatechuic Acid on the Treatment of Parkinson’s Disease
by: Tingting Wu, et al.
Published: (2020-08-01)

Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells
by: Junxia Pei, et al.
Published: (2023-04-01)

Protocatechuic aldehyde attenuates cisplatin-induced acute kidney injury by suppressing Nox-mediated oxidative stress and renal inflammation
by: Li Gao, et al.
Published: (2016-12-01)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
by: Bridget Martinez, et al.
Published: (2018-01-01)

Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.
by: Emanuela Esposito, et al.
Published: (2012-01-01)

Correction: Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells
by: Junxia Pei, et al.
Published: (2023-04-01)

Retraction Note: Protocatechuic aldehyde from Salvia miltiorrhiza exhibits an anti-inflammatory effect through inhibiting MAPK signalling pathway
by: Shuang Wu, et al.
Published: (2023-05-01)

Application of Neurotoxin-Induced Animal Models in the Study of Parkinson’s Disease-Related Depression: Profile and Proposal
by: Ya-Kui Mou, et al.
Published: (2022-05-01)

Potential Role of Protocatechuic Acid as Natural Feed Additives in Farm Animal Production
by: Shad Mahfuz, et al.
Published: (2022-03-01)

Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease
by: Claudio Giuliano, et al.
Published: (2021-08-01)

The Neuroprotection of Low-Dose Morphine in Cellular and Animal Models of Parkinson’s Disease Through Ameliorating Endoplasmic Reticulum (ER) Stress and Activating Autophagy
by: Bing Wang, et al.
Published: (2018-04-01)

Protocatechuic Aldehyde Inhibits α-MSH-Induced Melanogenesis in B16F10 Melanoma Cells via PKA/CREB-Associated MITF Downregulation
by: Seok-Chun Ko, et al.
Published: (2021-04-01)

Protocatechuic Aldehyde Attenuates UVA-induced Photoaging in Human Dermal Fibroblast Cells by Suppressing MAPKs/AP-1 and NF-κB Signaling Pathways
by: Yuling Ding, et al.
Published: (2020-06-01)

Use of Botulinum Neurotoxin in Parkinson’s Disease: A Critical Appraisal
by: Wolfgang H. Jost
Published: (2021-01-01)

Preparation and Characterization of Protocatechuic Acid Sulfates
by: Sofia M. Gutierrez-Zetina, et al.
Published: (2019-01-01)

Neuroprotective potential of Cordia dichotoma in Parkinson's syndrome induced by haloperidol: An animal study
by: Keserla Bhavani, et al.
Published: (2023-10-01)

Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
by: Ewelina Palasz, et al.
Published: (2019-11-01)

Striatal synaptic adaptations in Parkinson's disease
by: Weixing Shen, et al.
Published: (2022-06-01)

Botulinum Neurotoxin for Pain Management: Insights from Animal Models
by: Siro Luvisetto, et al.
Published: (2010-12-01)

Rapid Microfluidic Assay for the Detection of Botulinum Neurotoxin in Animal Sera
by: Lmar Babrak, et al.
Published: (2016-01-01)

Neuroprotection of phytic acid in Parkinson’s and Alzheimer’s disease
by: Yujie Chen, et al.
Published: (2023-11-01)

Neuroprotective Treatments in Parkinson’s Disease
by: Elif, et al.
Published: (2019-12-01)

Fetal exposure to environmental neurotoxins in Taiwan.
by: Chuen-Bin Jiang, et al.
Published: (2014-01-01)

Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson’s Disease: An Updated Review
by: Steven D. Mitchell, et al.
Published: (2021-03-01)

Ghrelin is neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic neuroprotection
by: Jacqueline A. Bayliss, et al.
Published: (2013-02-01)

Protection against Metabolic Associated Fatty Liver Disease by Protocatechuic Acid
by: Jijun Tan, et al.
Published: (2023-12-01)

The safety of botulinum neurotoxin type A's intraarticular application in experimental animals
by: Ana Dugonjić Okroša, et al.
Published: (2023-06-01)